Overview
Congenitally corrected transposition of the great arteries (ccTGA), also known as L-transposition of the great arteries or ventricular inversion, is a rare congenital heart defect in which the heart's two lower chambers (ventricles) are reversed. In this condition, the aorta arises from the morphologic right ventricle, and the pulmonary artery arises from the morphologic left ventricle. However, the atria are also connected to the opposite ventricles (atrioventricular discordance), so blood still flows in the correct physiological direction — deoxygenated blood reaches the lungs and oxygenated blood reaches the body. This double discordance is why the condition is described as 'congenitally corrected.' Despite the physiologically corrected circulation, ccTGA is associated with significant long-term complications. The morphologic right ventricle must function as the systemic ventricle, pumping blood against systemic pressures, a role for which it is not ideally suited. Over time, this can lead to systemic ventricular dysfunction and heart failure. The tricuspid valve, which serves as the systemic atrioventricular valve in ccTGA, is prone to progressive regurgitation. Conduction system abnormalities are common, with a significant proportion of patients developing complete heart block either spontaneously or after surgical intervention. Approximately 60–90% of patients with ccTGA have associated cardiac anomalies, most commonly ventricular septal defect (VSD), pulmonary stenosis or subpulmonary obstruction, and Ebstein-like malformation of the tricuspid valve. Some patients with isolated ccTGA (without associated defects) may remain asymptomatic for decades and may not be diagnosed until adulthood, when symptoms of heart failure, arrhythmias, or exercise intolerance develop. Treatment depends on the associated anomalies and the degree of systemic ventricular dysfunction. Surgical options include conventional repair (addressing associated defects while leaving the morphologic right ventricle as the systemic ventricle) or anatomic repair procedures such as the double switch operation, which restores the morphologic left ventricle to the systemic circulation. Pacemaker implantation may be required for heart block. Heart transplantation may be considered in cases of severe, refractory heart failure. Lifelong cardiology follow-up is essential for all patients with ccTGA.
Also known as:
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Congenitally corrected transposition of the great arteries.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenitally corrected transposition of the great arteries at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenitally corrected transposition of the great arteries.
Community
No community posts yet. Be the first to share your experience with Congenitally corrected transposition of the great arteries.
Start the conversation →Latest news about Congenitally corrected transposition of the great arteries
No recent news articles for Congenitally corrected transposition of the great arteries.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenitally corrected transposition of the great arteries
What is Congenitally corrected transposition of the great arteries?
Congenitally corrected transposition of the great arteries (ccTGA), also known as L-transposition of the great arteries or ventricular inversion, is a rare congenital heart defect in which the heart's two lower chambers (ventricles) are reversed. In this condition, the aorta arises from the morphologic right ventricle, and the pulmonary artery arises from the morphologic left ventricle. However, the atria are also connected to the opposite ventricles (atrioventricular discordance), so blood still flows in the correct physiological direction — deoxygenated blood reaches the lungs and oxygenated
How is Congenitally corrected transposition of the great arteries inherited?
Congenitally corrected transposition of the great arteries follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Congenitally corrected transposition of the great arteries?
3 specialists and care centers treating Congenitally corrected transposition of the great arteries are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.